Back
Franklin Responsibly Sourced Gold ETF Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison
Buy
85
FGDL
Franklin Responsibly Sourced Gold ETF
Last Price:
$59.81
Seasonality Move:
5.72%
Buy
60
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$784.09
Seasonality Move:
12.13%
Buy
85
Franklin Responsibly Sourced Gold ETF (FGDL)
is a Buy
Is Franklin Responsibly Sourced Gold ETF a Buy, Sell or Hold?
-
The current Franklin Responsibly Sourced Gold ETF [FGDL] share price is $59.81. The Score for FGDL is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
-
FGDL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
60
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $783.71. The Score for REGN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FGDL Stock Price Chart
What is Franklin Responsibly Sourced Gold ETF's stock price today?
-
The Franklin Responsibly Sourced Gold ETF share price today is $59.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FGDL is experiencing buying pressure, which is a positive indicator for future bullish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $783.71Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
FGDL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.09 | Buy |
| Relative Strength Index (14 RSI): | 76.32 | Buy |
| Chaikin Money Flow: | 14049 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.13 - 57.91) | Buy |
| Bollinger Bands (100): | (47.4 - 56.34) | Buy |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 204.17 | Buy |
| Relative Strength Index (14 RSI): | 67.2 | Buy |
| Chaikin Money Flow: | -261329 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (720.67 - 774.53) | Buy |
| Bollinger Bands (100): | (555.56 - 709.04) | Buy |
FGDL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.16 | Buy |
| 20-day SMA: | 56.98 | Buy |
| 50-day SMA: | 55.55 | Buy |
| 200-day SMA: | 47.7 | Buy |
| 8-day EMA: | 58.29 | Buy |
| 20-day EMA: | 57.15 | Buy |
| 50-day EMA: | 55.27 | Buy |
| 200-day EMA: | 48.45 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 764.21 | Buy |
| 20-day SMA: | 747.28 | Buy |
| 50-day SMA: | 691.09 | Buy |
| 200-day SMA: | 601.8 | Buy |
| 8-day EMA: | 603.24 | Buy |
| 20-day EMA: | 348.3 | Buy |
| 50-day EMA: | 164.33 | Buy |
| 200-day EMA: | 44.8 | Buy |
Franklin Responsibly Sourced Gold ETF Earnings Growth & FGDL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $0.97 per share.
Franklin Responsibly Sourced Gold ETF Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||